Resiliency Training on the College Campus
Psychotic Disorders, Mood Disorders, Anxiety Disorders
About this trial
This is an interventional prevention trial for Psychotic Disorders
Eligibility Criteria
Inclusion Criteria: 18-30 years old Enrolled in undergraduate program at the college or university where the intervention takes place Students who endorse delusion-like experiences (DLEs): Peter's et al. Delusion Inventory (PDI) score > 4 and/or Students with mild to moderate depressive symptoms: Beck Depression Inventory (BDI) score ≥ 6 Exclusion Criteria: Inability to provide informed consent Not proficient in English Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization Current enrollment in psychological or behavioral health treatment. Current use of psychotropic medications (other than stimulants) prescribed by a physician.
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Resilience Training
Waitlist
Participants obtained Resilience Training, a 4 session, 1.5 hour group intervention delivering the following skills: mindfulness, mentalization, and self-compassion.
A 4-6 week waitlist during which participants did not receive any treatment. They would then obtain Resilience Training following their waitlist period.